An exemplary anastomosis device comprises a proximal ring, a distal ring, and a middle ring. The middle ring has apertures configured to communicate a fluid such as an adhesive. The exemplary anastomosis device also has arms joining the proximal ring to the center member and arms joining the distal ring to the center member. The anastomosis device is configured to move from an unactuated position, where it has a generally cylindraceous configuration, to an actuated position, where it has a generally rivet-like configuration. The anastomosis device may be used to provide and secure an anastomosis between adjacent tissue walls. Adhesive may be communicated through the apertures of the middle ring of the anastomosis device to seal or strengthen the anastomosis. An applier may be used to deploy the anastomosis device and to communicate the adhesive through the apertures.
|
1. An anastomosis device operable to provide an anastomosis between two tissue walls, the anastomosis device comprising:
an anastomotic ring device, the anastomotic ring device comprising:
(a) a proximal ring defining a first opening,
(b) a distal ring defining a second opening, wherein the second opening is substantially coaxially aligned with the first opening,
(c) a center member positioned longitudinally between the proximal ring and the distal ring, wherein the center member comprises at least one transverse fluid port, wherein the fluid port is configured to communicate a fluid medium, wherein the center member defines a third opening, wherein the third opening is substantially coaxially aligned with the first and second openings,
(d) a proximal expandable portion joining the proximal ring to the center member, and
(e) a distal expandable portion joining the distal ring to the center member;
wherein the anastomotic ring device is configured to move from an unactuated position to an actuated position, wherein a first portion the anastomotic ring device has a first width when the anastomotic ring device is in the unactuated position, wherein the first portion of the anastomotic ring device has a second width when the anastomotic ring device is in the actuated position, wherein the second width is greater than the first width, wherein a second portion of the anastomotic ring device has a third width when the anastomotic ring device is in the unactuated position and when the anastomotic ring device is in the actuated position, wherein the second width is greater than the third width, wherein the first, second, and third openings together define an open passageway when the anastomotic ring device is in the actuated position, wherein the open passageway is configured to permit fluid communication through the proximal and distal rings, through the center member, and through the two tissue walls, wherein the transverse fluid port is transverse to the open passageway; and
an applier, wherein the anastomotic ring device is engaged with the applier, wherein the applier has at least one radial adhesive port, wherein the at least one radial adhesive port of the applier is radially aligned with the at least one transverse fluid port of the center member of the anastomotic ring device.
2. The anastomosis device of
3. The anastomosis device of
4. The anastomosis device of
5. The anastomosis device of
7. The anastomosis device of
8. The anastomosis device of
9. The anastomosis device of
10. The anastomosis device of
11. The anastomosis device of
12. The anastomosis device of
13. The anastomosis device of
14. The anastomosis device of
15. The anastomosis device of
16. The anastomosis device of
17. A method of using the anastomosis device of
positioning the anastomotic ring device at an anastomosis site;
deploying the anastomotic ring device at the anastomosis site, using the applier, to create an anastomosis; and
applying an adhesive at the anastomosis site, wherein the adhesive is applied adjacent to the anastomotic ring device.
18. The method of
19. The method of
|
Morbid obesity creates significant medical issues, often warranting treatment. One method of treating morbid obesity includes the use of anastomotic devices to create an anastomosis between two gastrointestinal tissue walls. Examples of such anastomosis devices are disclosed in U.S. Pub. No. 2005/0070935, the disclosure of which is incorporated by reference herein. While a variety of systems and methods have been made and used for creating anastomoses between gastrointestinal tissue walls or other body lumens, it is believed that no one prior to the inventors has made or used the invention described in the appended claims.
While the specification concludes with claims which particularly point out and distinctly claim the invention, it is believed the present invention will be better understood from the following description of certain examples taken in conjunction with the accompanying drawings, in which like reference numerals identify the same elements and in which:
The following description of certain examples of the invention should not be used to limit the scope of the present invention. Other examples, features, aspects, embodiments, and advantages of the invention will become apparent to those skilled in the art from the following description, which is by way of illustration, one of the best modes contemplated for carrying out the invention. As will be realized, the invention is capable of other different and obvious aspects, all without departing from the invention. Accordingly, the drawings and descriptions should be regarded as illustrative in nature and not restrictive.
One technique for providing an anastomosis is to use an anastomotic ring device. An exemplary anastomotic ring device is disclosed in U.S. Pub. No. 2005/0070935 to Ortiz, the disclosure of which is incorporated by reference herein. Another exemplary anastomotic ring device is disclosed in U.S. Pub. No. 2003/0032967 to Park et al., the disclosure of which is incorporated by reference herein. Yet another exemplary anastomotic ring device is disclosed in U.S. Pub. No. 2005/0070934 to Tanaka et al., the disclosure of which is incorporated by reference herein. Other suitable anastomotic ring devices will be apparent to those of ordinary skill in the art, while another exemplary anastomotic ring device (60) will be described in greater detail below. In particular, the anastomotic ring device (60) of the present example is shown in
As shown in
Anastomotic ring device (60) comprises a proximal ring (62), a middle ring (64), and a distal ring (66). Rings (62, 64, 66) lie along a common axis. Proximal ring (62) is attached to middle ring (64) via a plurality of proximal arms (70). Each proximal arm (70) comprises a first segment (72) and a second segment (74). Each first segment (72) of each proximal arm (70) is in a hinged relationship with the second segment (72) of the corresponding proximal arm (70). Each first segment (72) of each proximal arm (70) is also in a hinged relationship with proximal ring (62). Each second segment (74) of each proximal arm (70) is in a hinged relationship with middle ring (64). In other words, proximal arms (70) are configured to hingedly flex, such that proximal ring (62) may be moved in a longitudinal direction toward and away from middle ring (64). In the present example, proximal arms (70) comprise a unitary plastic material, such that the hinged relationships described above are provided by bending of the material. Alternatively, proximal arms (70) may comprise other materials or configurations (e.g., first segment (72) and second segment (74) may be separate pieces joined together).
Similarly, distal ring (66) is attached to middle ring (64) via a plurality of distal arms (80). Each distal arm (80) comprises a first segment (82) and a second segment (84). Each first segment (82) of each distal arm (80) is in a hinged relationship with the second segment (82) of the corresponding distal arm (80). Each first segment (82) of each distal arm (80) is also in a hinged relationship with distal ring (66). Each second segment (84) of each distal arm (80) is in a hinged relationship with middle ring (64). In other words, distal arms (80) are configured to hingedly flex, such that distal ring (82) may be moved in a longitudinal direction toward and away from middle ring (64). In the present example, distal arms (80) comprise a unitary plastic material, such that the hinged relationships described above are provided by bending of the material. Alternatively, distal arms (80) may comprise other materials or configurations (e.g., first segment (82) and second segment (84) may be separate pieces joined together).
It will be appreciated that anastomotic ring device (60) may move from an unactuated position to an actuated position (or vice-versa) through hinged flexure of proximal arms (70) and distal arms (80); such that proximal ring (62) moves longitudinally and distally toward middle ring (64), and distal ring (66) moves longitudinally and proximally toward middle ring (64). Anastomotic ring device (60) of the present example is also configured such that it is biased to maintain an actuated position. In other words, an anastomotic ring device (60) that is in an unactuated position may be under a resilient strain to reach an actuated position; and an actuated anastomotic ring device (60) may resist movement toward an unactuated position. Alternatively, anastomotic ring device (60) may have another configuration or other properties, such that anastomotic ring device (60) moves from an unactuated position to an actuated position using some other type of action or structure. By way of example only, anastomotic ring device (60) may be malleable.
In another embodiment (not depicted), arms (70, 80) of anastomotic ring device (60) are substituted with one or more inflatable members. For instance, a proximal inflatable member may be positioned between proximal ring (62) and middle ring (64); and a distal inflatable member between middle ring (64) and distal ring (66). In this embodiment, each of the inflatable members may be in fluid communication with a source of a pressurized medium (e.g., air, liquid, etc.) via applier (10) or via another device. When such inflatable members are not inflated, this alternative anastomotic ring device (60) may be in an unactuated position. When the inflatable members are inflated, the alternative anastomotic ring device (60) may be in an actuated position. In other words, and similar to anastomotic ring device (60) shown in the drawings, this particular alternative anastomotic ring device (60) may have a length that is greater than its width in an unactuated position; and a width that is greater than its length in an actuated position. Alternatively, the effective width of an anastomotic ring device (60), whether it is the anastomotic ring device (60) shown in the drawings, the alternative anastomotic ring device (60) with inflatable members, or in some other embodiment, may otherwise be greater in an actuated position than in an unactuated position (e.g., regardless of whether the length of the device undergoes any change from one position relative another). Still other suitable substitutes and variations of arms (70, 80) will be apparent to those of ordinary skill in the art.
As is also shown in FIGS. 1 and 3-12, proximal arms (70) and distal arms (80) of the present example are radially staggered or offset from one another as to their respective angular positions about the circumference of middle ring (64). Alternatively, proximal arms (70) and distal arms (80) may be positioned along the circumference of middle ring (64) such that they are aligned with each other, or may have any other suitable relative configuration.
In the present example, middle ring (64) comprises a plurality of apertures (68). Apertures (68) are configured to permit passage of an adhesive therethrough, such that apertures (68) act as fluid ports. As will be described in greater detail below, when anastomotic ring device (60) is used to provide and secure an anastomosis, an adhesive may be passed through apertures (68) to provide further sealing and securing of the anastomosis. An exemplary adhesive is disclosed in U.S. Pub. No. 2004/0190975, the disclosure of which is incorporated by reference herein. A suitable adhesive may comprise a cyanoacrylate, an isocyanate, and/or any other suitable substance, including combinations of substances.
Applier (10) of the present example is operable to hold and deploy an anastomotic ring device (60) (e.g., move anastomotic ring device (60) from an unactuated position to an actuated position). Applier (10) is further operable to dispense an adhesive through apertures (68) of middle ring (64) of anastomotic ring device (60). Applier (10) comprises a handle (12) and a shaft (14) extending distally from the handle (12). The distal end of the shaft (14) comprises an introducer tip (16). In the present example, introducer tip (16) is pointed, and is configured to penetrate tissue such as the wall of a stomach (104) and/or a jejunum (102). Alternatively, an introducer tip (16) may be rounded, blunt, or have any other suitable configuration.
As shown in
Retaining members (30) each comprise three radial post members (32) and a resilient member (34). While three radial post members (32) are shown in the present example, it will be appreciated that any other number of radial post members (34) may be used. Radial post members (32) of a given retaining member (30) are engaged with a respective resilient member (34). As shown, resilient member (34) comprises a generally annular ring portion. While resilient member (34) of this example does not form a complete circle, resilient member (34) may form a complete circle (or any other shape or shape portion) in suitable alternative embodiments. Resilient member (34) is biased to have a first diameter, but may be urged to reach and be held at a second diameter that is greater than the first diameter. Accordingly, with radial post members (34) being engaged with a corresponding resilient member (34), a retaining member (30) may be resistingly held such that resilient member (34) is at a second diameter; then the retaining member (30) may radially contract upon release of the retaining member (30), as the bias of resilient member (34) causes resilient member (34) to reach a first diameter.
An example of radial contraction by a retaining member (30) is shown in
As shown in
As noted above, shaft (12) further comprises a retractable rod (40) within a bore (42). Retractable rod (40) and bore (42) are aligned along the axis of shaft (12) in the present example, though they may be positioned elsewhere. Retractable rod (40) has a first segment (44) and a second segment (46) that is proximal to the first segment (44). Second segment (46) has a diameter that is greater than the diameter of first segment (44). A tapered tip (48) is provided at the distal end of first segment (44), while a tapered section (49) provides a ramped transition from first segment (44) to second segment (46). In another embodiment, tapered tip (48) is omitted, such that the distal end of first segment (44) is substantially flat. Alternatively, the distal end of first segment may have any other suitable configuration. Similarly, tapered section (49) may have a variety of alternative configurations. By way of example only, tapered section (49) may alternatively be concave, convex, or may be a simple step extending in radial direction. In the present example, bore (42) is configured with surface features mirroring the configuration of the first segment (44), second segment (46), and tapered section (49), though bore (42) may have any other suitable configuration.
As shown in
As shown in
As shown in
As shown in
Handle (12) of the present example comprises a grip member (13) and a knob (15). In one embodiment, squeezing the grip member (13) causes retractable rod (40) to retract; while rotation of knob (15) causes adhesive to be dispensed through conduits (50) as described in greater detail below. In another embodiment, squeezing the grip member (13) causes adhesive to be dispensed through conduits (50); while rotation of knob (15) causes retractable rod (40) to retract. Of course, handle (12) may comprise any other suitable features in addition to or in lieu of grip member (13) and knob (15); and any other suitable feature(s) may be used to cause retraction of retractable rod (40) and/or dispensation of adhesive through conduits (50).
As also noted above, and as shown in
In the present example, the number of radial adhesive ports (52) is equal to the number of apertures (68) in anastomotic ring device (60). Furthermore, radial adhesive ports (52) are configured such that each adhesive port (52) may be radially aligned with a corresponding aperture (68) of anastomotic ring device (60). In the present example, and as shown in
In one embodiment, anastomotic ring device (60) comprises a biodegradable or bioabsorbable plastic material. For instance, anastomotic ring device (60) may degrade at some time after implantation. Anastomotic ring device (60) may be completely or partially absorbed. Alternatively, anastomotic ring device (60) may degrade and fragment, with at least part of the fragments being passed through the patient's gastrointestinal tract. To the extent that an anastomotic ring device (60) has degraded and/or been absorbed, an anastomosis may be maintained by scar tissue, adhesive, and/or by any other device, technique, or phenomenon. Alternatively, an anastomotic ring device (60) may be formed of any other suitable material(s) having any other suitable properties.
In an exemplary use of applier (10) and anastomotic ring device (60), a patient's jejunum (102) is grasped with tissue graspers (106) and positioned adjacent to the patient's stomach (104), such as is shown in
Next, in the present exemplary use, adhesive is dispensed at the anastomosis site (100) via apertures (68) as described above. With the adhesive dispensed, and as shown in
It will be appreciated that any of the foregoing steps in the exemplary use described above may be modified, substituted, supplemented, or omitted as appropriate. Furthermore, it will be appreciated that such a method may be performed using any other suitable devices to substitute, supplement, or modify applier (10) and/or anastomotic ring device (60). By way of example only, applier (10) may be configured such that at least a portion of applier may be passed through a patient's esophagus to reach an anastomosis site (100) from the interior of the stomach (104). Alternatively, applier (10) may be configured such that at least a portion of applier (10) may be presented to an anastomosis site (100) via a trocar or other cannula. In yet another variation, applier (10) is configured to be used in an open procedure. Still other structural and procedural variations will be apparent to those of ordinary skill in the art.
Embodiments of the present invention have application in conventional endoscopic and open surgical instrumentation as well as application in robotic-assisted surgery.
Embodiments of the devices disclosed herein can be designed to be disposed of after a single use, or they can be designed to be used multiple times. Embodiments may, in either or both cases, be reconditioned for reuse after at least one use. Reconditioning may include any combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, embodiments of the device may be disassembled, and any number of the particular pieces or parts of the device may be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, embodiments of the device may be reassembled for subsequent use either at a reconditioning facility, or by a surgical team immediately prior to a surgical procedure. Those skilled in the art will appreciate that reconditioning of a device may utilize a variety of techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.
By way of example only, embodiments described herein may be processed before surgery. First, a new or used instrument may be obtained and if necessary cleaned. The instrument may then be sterilized. In one sterilization technique, the instrument is placed in a closed an sealed container, such as a plastic or TYVEK bag. The container and instrument may then be placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons. The radiation may kill bacteria on the instrument and in the container. The sterilized instrument may then be stored in the sterile container. the sealed container may keep the instrument sterile until it is opened in a medical facility. A device may also be sterilized using any other technique known in the art, including but not limited to beta or gamma radiation, ethylene oxide, or steam.
Having shown and described various embodiments of the present invention, further adaptations of the methods and systems described herein may be accomplished by appropriate modifications by one of ordinary skill in the art without departing from the scope of the present invention. Several of such potential modifications have been mentioned, and others will be apparent to those skilled in the art. For instance, the examples, embodiments, geometries, materials, dimensions, ratios, steps, and the like discussed above are illustrative and are not required. Accordingly, the scope of the present invention should be considered in terms of the following claims and is understood not to be limited to the details of structure and operation shown and described in the specification and drawings.
Ortiz, Mark S., Shelton, IV, Fredrick E.
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
4735616, | Jun 20 1985 | Immuno Aktiengesellschaft fur chemisch-medizinische Produkte | Arrangement for applying a tissue adhesive |
4766898, | Oct 20 1980 | Sherwood Services AG | Anastomotic device |
4874368, | Jul 25 1988 | Micromedics, Inc. | Fibrin glue delivery system |
5004469, | Mar 07 1989 | Ricerche Biomediche S.r.l. | Improvements in automatic mechanical suturing guns |
5154320, | Dec 23 1985 | Ethicon, Inc | Aerosol spray system |
5254113, | Aug 31 1992 | Anastomosis method | |
5312333, | Apr 03 1992 | United States Surgical Corporation | Endoscopic material delivery device |
5324305, | Dec 15 1992 | ATRION MEDICAL PRODUCTS, INC | Bioadhesive applicator |
5372585, | Apr 09 1992 | Wilk Patent Development Corporation | Instrument and associated method for applying biologically effective composition during laparoscopic operation |
5443481, | Jul 27 1992 | Methods and device for percutaneous sealing of arterial puncture sites | |
5474540, | Mar 25 1994 | Nordson Corporation | Fluid separation control attachment for physiologic glue applicator |
5529577, | Sep 28 1993 | HEMODYNAMICS, INC | Surface opening adhesive sealer |
5582596, | Sep 26 1992 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Applicator for applying a biocompatible adhesive |
5605541, | Dec 08 1994 | E R SQUIBB & SONS, LLC; VIVOLUTION A S | Fibrin sealant applicatoor |
5718711, | Oct 15 1993 | STRYKER EUROPEAN HOLDINGS III, LLC | Ultrasoft embolism devices and process for using them |
5752965, | Oct 21 1996 | SYNOVIS LIFE TECHNOLOGIES, INC | Apparatus and method for producing a reinforced surgical fastener suture line |
5759169, | Mar 13 1996 | U V GROUP, INC | Fibrin sealant glue-gun |
5759171, | Sep 27 1996 | ASAHI KASEI MEDICAL CO , LTD | Sprayer for fibrin glue |
5814022, | Feb 06 1996 | Plasmaseal LLC | Method and apparatus for applying tissue sealant |
5844087, | Nov 05 1996 | TALECRIS BIOTHERAPEUTICS, INC | Method and device for delivering fibrin glue |
5853422, | Mar 22 1996 | Boston Scientific Scimed, Inc | Apparatus and method for closing a septal defect |
5895412, | Oct 11 1995 | Baxter International Inc; BAXTER HEALTHCARE S A | Device and method for sealing tissue |
5928611, | Jun 07 1995 | Ethicon, Inc | Impregnated applicator tip |
5981621, | Feb 29 1996 | Ethicon, Inc | Monomeric compositions effective as wound closure devices |
6007515, | Apr 15 1997 | BAXTER INTERNATIONAL, INC | Controlled action, manually operable fluid application |
6010714, | Nov 22 1996 | Closure Medical Corporation; Tri-Point Medical Corporation | Non-thermogenic heat dissipating biomedical adhesive compositions |
6055828, | Dec 30 1997 | Ethicon, Inc | Treatment methods for glass medical adhesive applicators |
6099807, | Jun 07 1995 | Closure Medical Corporation | Impregnated applicator tip |
6113571, | Sep 10 1996 | OMRIX BIOPHARMACEUTICALS S A | Applicator device for applying a multiple component fluid |
6143352, | Jun 28 1994 | Ethicon, Inc | pH-modified biocompatible monomer and polymer compositions |
6143805, | Feb 18 1998 | Ethicon, Inc | Electron beam sterilization of liquid adhesive compositions |
6162239, | Jul 11 1996 | KARL STORZ GMBH & CO KG | Instrument with independent pliers |
6174919, | Feb 18 1998 | Ethicon, Inc | Cyanoacrylate compositions with vinyl terminated ester groups |
6183593, | Dec 23 1999 | Ethicon, Inc | 1,1-disubstituted ethylene adhesive compositions containing polydimethylsiloxane |
6206905, | Nov 15 1996 | VIVOLUTION A S | Devices and methods for applying a mixture of two or more liquid components to form a biomaterial |
6217603, | Aug 29 1997 | Ethicon, Inc | Methods of applying monomeric compositions effective as wound closure devices |
6228051, | Mar 27 1997 | VIVOLUTION A S | Laparoscopic sealant applicator |
6234994, | Sep 10 1996 | OMRIX Biopharmaceuticals SA | Multicomponent tissue adhesive application device and holder for such device |
6245933, | Nov 19 1999 | Ethicon, Inc | Transesterification method for making cyanoacrylates |
6280399, | Oct 06 1998 | Merit Medical Systems, Inc | Substance delivery device for use with a procedure performing instrument |
6283933, | Dec 23 1998 | Ethicon, Inc | Applicator for dispensable liquids |
6302898, | Jul 07 1994 | Neomend, Inc | Devices for sealing punctures in body vessels |
6306243, | Jun 28 1994 | Closure Medical Corporation | pH-modified biocompatible monomer and polymer compositions |
6310166, | Aug 12 1999 | Ethicon, Inc | Sterilized cyanoacrylate solutions containing thickeners |
6322852, | Jun 07 1995 | Closure Medical Corporation | Impregnated applicator tip |
6325810, | Jun 30 1999 | Ethicon, Inc | Foam buttress for stapling apparatus |
6340097, | Oct 22 1998 | Ethicon, Inc | Applicator with protective barrier |
6352704, | Jun 30 1999 | Ethicon, Inc | Flavored cyanoacrylate compositions |
6372313, | Sep 01 1998 | Ethicon, Inc | Package assembly with applicator and container for adhesive materials |
6376019, | Jun 07 1995 | Closure Medical Corporation | Impregnated applicator tip |
6394975, | Jun 23 1989 | BAXTER INTERNATIONAL, INC | Method to apply compositions to a surface |
6394982, | Jul 11 1997 | United States Surgical | Fibrin glue applicator system |
6398797, | Jul 28 1999 | Aesculap AG | Tissue bonding system and method for controlling a tissue site during anastomosis |
6412639, | Apr 28 2000 | Ethicon, Inc | Medical procedure kit having medical adhesive |
6420590, | Oct 31 2000 | Ethicon, Inc | Continuous processes and apparatus for forming cyanoacetate and cyanoacrylate |
6425704, | Jan 07 2000 | Ethicon, Inc | Adhesive applicators with improved applicator tips |
6428233, | Jan 07 2000 | Ethicon, Inc | Adhesive applicator tips with improved flow properties |
6428234, | Jan 07 2000 | Ethicon, Inc | Adhesive applicator tips with improved flow properties |
6432084, | May 08 2000 | BAXTER INTERNATIONAL, INC | Non-newtonian fluid spray applicator and method |
6433096, | Aug 12 1999 | Closure Medical Corporation | Sterilized cyanoacrylate solutions containing thickeners |
6439789, | Sep 27 2000 | Ethicon, Inc | Polymerizable 1, 1-disubstituted ethylene monomer formulation applicators, applicator tips, applicator kits and methods |
6454739, | Sep 13 1999 | Korea Greencross Corp. | Fibrin sealant delivery device |
6455064, | Apr 30 1998 | Ethicon, Inc | Method of applying an adhesive composition over a bioactive polymerization initiator or accelerator |
6458095, | Oct 22 1997 | Neomend, Inc | Dispenser for an adhesive tissue sealant having a housing with multiple cavities |
6461361, | May 01 1998 | BAXTER INTERNATIONAL, INC | Gas-driven spraying of mixed sealant agents |
6461367, | Jul 16 1999 | Loma Linda University Medical Center; LOMA UNIVERSITY MEDICAL CENTER | Method and device for urethral-vesicle anastomosis |
6464663, | Mar 11 1997 | OMRIX Biopharmaceuticals SA | Applicator for applying a single--or multicomponent fluid and method for spraying such a fluid |
6468520, | Mar 23 1993 | Focal, Inc. | Apparatus and method for local application of polymeric material to tissue |
6471670, | Oct 05 1998 | United States Surgical | Fibrin sealant applicator system |
6478191, | Oct 22 1998 | Closure Medical Corporation | Applicator with protective barrier |
6488197, | Feb 22 2000 | Covidien LP | Fluid delivery device for use with anastomosing resecting and stapling instruments |
6488650, | Jun 03 1998 | BAXTER INTERNATIONAL, INC | Direct dual filling device for sealing agents |
6488944, | Dec 23 1999 | Ethicon, Inc | 1, 1-disubstituted ethylene adhesive compositions containing polydimethylsiloxane |
6491201, | Feb 22 2000 | Covidien LP | Fluid delivery mechanism for use with anastomosing, stapling, and resecting instruments |
6494896, | Nov 30 1999 | Ethicon, Inc | Applicator for laparoscopic or endoscopic surgery |
6512023, | Jun 18 1998 | Ethicon, Inc | Stabilized monomer adhesive compositions |
6527749, | Dec 19 1997 | United States Surgical Corporation | Two component dispenser system |
6540716, | May 06 1998 | VIVOLUTION A S | Directional endoscopic delivery of material |
6547467, | Aug 29 2001 | Ethicon, Inc | Microapplicators, delivery systems and methods for adhesives and sealants |
6565840, | Feb 29 1996 | Closure Medical Corporation | Monomeric compositions effective as wound closure devices |
6579469, | Oct 29 1999 | Ethicon, Inc | Cyanoacrylate solutions containing preservatives |
6585967, | Jul 05 2001 | Ethicon, Inc | Adhesive treatment for tinea cruris |
6589269, | Feb 24 2000 | Loma Linda University Medical Center | Patch and glue delivery system for closing tissue openings during surgery |
6592281, | Jan 07 2000 | Closure Medical Corporation | Adhesive applicator tips with improved flow properties |
6595940, | Dec 23 1998 | Ethicon, Inc | Applicator for dispensable liquids |
6602496, | Jul 05 2001 | Ethicon, Inc | Adhesive treatment for tinea corporis |
6605667, | Sep 08 2000 | Ethicon, Inc | Antioxidant enriched adhesive compositions and storage containers therefor |
6607631, | Sep 08 2000 | Ethicon, Inc | Adhesive compositions with reduced coefficient of friction |
6613020, | Dec 06 1996 | VIVOLUTION A S | Method of applying a mixture of two liquid components as well as a device for carrying out the method |
6616019, | Jul 18 2001 | Ethicon, Inc | Adhesive applicator with improved applicator tip |
6620846, | Aug 02 2000 | Ethicon, Inc | Absorbable adhesive compositions |
6637967, | Jan 07 2000 | Closure Medical Corporation | Adhesive applicator tips with improved flow properties |
6666873, | Aug 08 2002 | Surgical coupler for joining tubular and hollow organs | |
6676322, | Jun 07 1995 | Closure Medical Corporation | Impregnated applicator tip |
6681979, | Feb 22 2000 | Covidien LP | Fluid delivery device for use with anastomosing stapling, and resecting instruments |
6695199, | Feb 22 2000 | Covidien LP | Fluid delivery mechanism for use with anastomosing, stapling, and resecting instruments |
6705790, | Jan 07 2000 | Ethicon, Inc | Adhesive applicators with improved applicator tips |
6719768, | Apr 29 2000 | Medtronic, Inc | Magnetic components for use in forming anastomoses, creating ports in vessels and closing openings in tissue |
6743858, | Aug 12 1999 | Closure Medical Corporation | Sterilized cyanoacrylate solutions containing thickeners |
6746667, | Jul 05 2001 | JOHNSON & JOHNSON CONSUMER INC | Adhesive treatment for tinea pedis |
6748950, | Apr 30 2001 | Ethicon, Inc | Compositions and medical procedure to treat snoring |
6764467, | Dec 19 1997 | United States Surgical Corporation | Fibrin mixture and dispenser assembly |
6767552, | Jul 05 2001 | Ethicon, Inc | Adhesive treatment for oral fungal infection |
6779657, | Jun 06 2001 | Ethicon, Inc | Single-use applicators, dispensers and methods for polymerizable monomer compound |
6783514, | Jan 31 1997 | United States Surgical Corporation | Fibrin sealant applicator |
6802416, | Sep 01 1998 | Ethicon, Inc | Package assembly with applicator and container for adhesive materials |
6802822, | Mar 31 2000 | Neomend, Inc | Dispenser for an adhesive tissue sealant having a flexible link |
6811341, | Aug 16 2001 | Ethicon, Inc | Multiple-component combining |
6837027, | Apr 28 2000 | Closure Medical Corporation | Method of sterilizing a medical procedure kit containing a medical adhesive |
6863660, | Mar 27 2002 | HAPTO BIOTECH, INC | Fibrin applicator pistol |
6884232, | Oct 31 2003 | Baxter International Inc; BAXTER HEALTHCARE SA | Laparoscopic spray device and method of use |
6896684, | Jun 12 2000 | NITI SURGICAL SOLUTIONS LTD | Surgical clip applicator device |
6896838, | Nov 21 2001 | Ethicon, Inc | Halogenated polymeric containers for 1, 1-disubstituted monomer compositions |
6921381, | Oct 05 2001 | Baxter International Inc; BAXTER HEALTHCARE S A | Laparoscopic spray device and method of use |
6942875, | Jul 05 2001 | Ethicon, Inc | Adhesive treatment for skin yeast infections |
6960040, | Sep 01 1998 | Closure Medical Corporation | Package assembly with applicator and container for adhesive materials |
7037344, | Nov 01 2002 | VALENTX, INC | Apparatus and methods for treatment of morbid obesity |
7608086, | Sep 30 2003 | ETHICON-ENDO SURGERY, INC | Anastomosis wire ring device |
20020012678, | |||
20020037310, | |||
20020048480, | |||
20020055573, | |||
20020065336, | |||
20020119184, | |||
20020147462, | |||
20020156203, | |||
20020157675, | |||
20020165483, | |||
20020173770, | |||
20020176732, | |||
20020176733, | |||
20020185396, | |||
20020192011, | |||
20020192107, | |||
20030007826, | |||
20030007946, | |||
20030007947, | |||
20030007948, | |||
20030007949, | |||
20030015557, | |||
20030031499, | |||
20030032833, | |||
20030032967, | |||
20030039781, | |||
20030044219, | |||
20030060380, | |||
20030063944, | |||
20030080151, | |||
20030082116, | |||
20030096069, | |||
20030149128, | |||
20030181964, | |||
20030202956, | |||
20040026282, | |||
20040059283, | |||
20040111115, | |||
20040120849, | |||
20040137067, | |||
20040143290, | |||
20040151688, | |||
20040190975, | |||
20040223932, | |||
20040223946, | |||
20040234578, | |||
20040243155, | |||
20040254561, | |||
20050033328, | |||
20050042266, | |||
20050047846, | |||
20050070935, | |||
20050070939, | |||
20050145671, | |||
20050147457, | |||
20050175395, | |||
20050182443, | |||
20050184121, | |||
20050220849, | |||
20050228446, | |||
20050230453, | |||
20050256446, | |||
20060009099, | |||
20060135992, | |||
20070142850, | |||
D500085, | Feb 07 2003 | Ethicon, Inc | Adhesive dispenser/applicator device |
EP315222, | |||
EP648510, | |||
EP669100, | |||
EP716833, | |||
EP1073484, | |||
EP1078600, | |||
EP1113839, | |||
EP1159081, | |||
EP1381321, | |||
EP1411836, | |||
JP10262986, | |||
JP2000217830, | |||
JP2001157716, | |||
JP2001190558, | |||
JP2002233581, | |||
JP2003126268, | |||
JP2005028009, | |||
JP2005169125, | |||
WO112257, | |||
WO124869, | |||
WO162158, | |||
WO162162, | |||
WO162333, | |||
WO2067785, | |||
WO3088845, | |||
WO9209651, | |||
WO9531137, | |||
WO9841154, | |||
WO9917833, | |||
WO9930629, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Nov 01 2006 | Ethicon Endo-Surgery, Inc. | (assignment on the face of the patent) | / | |||
Nov 08 2006 | ORTIZ, MARK S | ETHICON-ENDO SURGERY, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 018604 | /0344 | |
Nov 09 2006 | SHELTON, FREDERICK E , IV | ETHICON-ENDO SURGERY, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 018604 | /0344 |
Date | Maintenance Fee Events |
Apr 19 2018 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Apr 20 2022 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
Date | Maintenance Schedule |
Nov 04 2017 | 4 years fee payment window open |
May 04 2018 | 6 months grace period start (w surcharge) |
Nov 04 2018 | patent expiry (for year 4) |
Nov 04 2020 | 2 years to revive unintentionally abandoned end. (for year 4) |
Nov 04 2021 | 8 years fee payment window open |
May 04 2022 | 6 months grace period start (w surcharge) |
Nov 04 2022 | patent expiry (for year 8) |
Nov 04 2024 | 2 years to revive unintentionally abandoned end. (for year 8) |
Nov 04 2025 | 12 years fee payment window open |
May 04 2026 | 6 months grace period start (w surcharge) |
Nov 04 2026 | patent expiry (for year 12) |
Nov 04 2028 | 2 years to revive unintentionally abandoned end. (for year 12) |